Cut-throat Culture at SP - Recensione dipendente - Director presso Merck

2,0
20 nov 2009
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great compensation, benefits, the majority of middle management are highly professional, pipeline is very strong for the US and ex-US (the latter being the growth driver for the company). Merck acquisition will right-size the back-stabbing, shoot-from-the-hip mentality at SGP.

Svantaggi

Senior management is ingrained with the Fred Hassan mentality of take-no-prisoners, push forward without regard for professionalism and treating employees fairly and honestly. However, every executive mgmt leader is gone through the merger .. except one. SGP management absolutely demolished Organon employee morale and good standing.

Esplora altre recensioni su Merck

5,0
11 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Amazing to work and smart people to work around.

Svantaggi

Not sponsoring in the US

4,0
2 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Svantaggi

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Vedi recensioni per: Utile|Valutazione|Data|Tutto